CompletedNot Applicable

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

United States1,456 participantsStarted 2022-07-01

Plain-language summary

The aims of this study will be to identify the clinical characteristics, the management and the outcomes of acute kidney injury in patients with cirrhosis worldwide. Specific aims: 1. To establish the severity of AKI across different regions 2. To identify precipitants of AKI across different centers 3. To identify the phenotypes of AKI across different centers 4. To evaluate differences in the management of AKI across different centers and their impact on clinical outcomes 5. To assess outcomes of acute kidney injury (resolution of AKI, in-hospital mortality, 28-day mortality, 90-day mortality)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Age \< 18 years old;
✕. Pregnancy;
✕. Hepatocellular carcinoma outside Milan criteria (i.e., a single lesion \<5 cm or multiple lesions \[maximum of three\], the largest of which measures ≤ 3 cm);
✕. Extrahepatic malignancy other than non-melanoma skin cancer within last 5 years;
✕. Previously known severe extrahepatic diseases (e.g., chronic renal failure requiring hemodialysis, severe congestive heart disease \[NYHA class ≥ 3\]; severe chronic obstructive pulmonary disease \[GOLD class ≥ 3\], psychiatric disorders);
✕. Previous solid organ transplantation;
✕. HIV infection with CD4 ≤ 250/µL;
✕. Patients who cannot provide prior informed consent and no legal surrogate decision maker

What they're measuring

90-day Mortality

Timeframe: 90 days

Trial details

NCT IDNCT05387811

SponsorAzienda Ospedaliera di Padova

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Liver Cirrhosis trials